UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 2, 2016
(Exact name of registrant as specified in its charter)
|
Delaware
|
0-21121
|
06-1456680
|
|
(State or other jurisdiction of incorporation)
|
(Commission file number)
|
(I.R.S. employer identification no.)
|
|
One Hamden Center
|
|
|
2319 Whitney Ave, Suite 3B, Hamden, CT
|
06518
|
|
(Address of principal executive offices)
|
(Zip Code)
|
Registrant's telephone number, including area code: (203) 859-6800
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240-14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 2.02 Results of Operations and Financial Condition.
The following information is being furnished pursuant to Item 2.02 “Results of Operations and Financial Condition” of Form 8-K. Such information, including the Exhibit attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.
On November 2, 2016, TransAct issued a press release announcing its financial results for the quarter ended September 30, 2016. A copy of the press release is furnished as Exhibit 99.1 to this report.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits:
|
Exhibit
|
Description
|
|
|
99.1
|
Press Release dated November 2, 2016 of TransAct Technologies Incorporated
|
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
TRANSACT TECHNOLOGIES INCORPORATED
|
||||
|
By:
|
/s/Steven A. DeMartino
|
|||
|
Steven A. DeMartino
|
||||
|
President, Chief Financial Officer, Treasurer and Secretary
|
||||
Date: November 2, 2016
Exhibit 99.1
TRANSACT TECHNOLOGIES REPORTS 2016 THIRD QUARTER RESULTS
Reports 2016 Third Quarter Revenue of $14.5 Million and GAAP Diluted EPS of $0.12
Hamden, CT – November 2, 2016 – TransAct Technologies Incorporated (Nasdaq: TACT) (“TransAct” or the “Company”), a global leader in software-driven technology and printing solutions for high-growth markets, today reported operating results for the third quarter and nine months ended September 30, 2016, as summarized below:
Summary of 2016 Q3 Results
(In millions, except per share and percentage data)
|
Three Months Ended
September 30,
|
|||||||
|
2016
|
2015
|
||||||
|
Net sales
|
$ | 14.5 | $ | 14.2 | |||
|
Gross profit
|
$ | 5.9 | $ | 6.3 | |||
|
Gross margin
|
40.9% | 44.4% | |||||
|
Operating income
|
$ | 1.2 | $ | 1.6 | |||
|
Net income
|
$ | 0.9 | $ | 1.0 | |||
|
Net income per diluted share
|
$ | 0.12 | $ | 0.13 | |||
|
Non-GAAP(1):
|
|||||||
|
Adjusted operating income
|
$ | 1.2 | $ | 1.6 | |||
|
EBITDA
|
$ | 1.6 | $ | 1.9 | |||
|
Adjusted EBITDA
|
$ | 1.7 | $ | 2.0 | |||
|
Adjusted net income
|
$ | 0.9 | $ | 1.0 | |||
|
Adjusted net income per diluted share
|
$ | 0.12 | $ | 0.13 | |||
|
(1)
|
A reconciliation of each non-GAAP financial measure to the most comparable Generally Accepted Accounting Principles (“GAAP”) financial measure can be found attached to this release. See “Non-GAAP Financial Measures” below for a discussion of these metrics.
|
Bart Shuldman, Chairman and Chief Executive Officer of TransAct, commented, “Third quarter sales in our POS automation business were strong and interest in our AccuDate line of food safety terminals continued to accelerate as we made notable progress in securing new approvals with restaurant and food service operators that we believe will support future sales momentum. Quarterly highlights also included the completion of a new international installation of our Epicentral software-based promotions and bonusing print system and the debut of new innovations for our Epicentral product line that will allow us to tap into growing industry interest in this innovative solution.
“Throughout the quarter, we made continued progress in further developing what we believe is a solid long-term growth opportunity for our food safety business. Restaurant operators have demonstrated increased interest in utilizing our technology for food safety automation while also pursuing our AccuDate terminals for additional back-of-the-restaurant operations. Given these factors, our AccuDate line of food safety terminals including the AccuDate 9700, AccuDate PRO and AccuDate XL uniquely position TransAct to provide a full suite of solutions that address the varying and growing needs of the restaurant and food service industry. Restaurant and other hospitality operators are working closely with TransAct to develop customized solutions using our AccuDate Pro and AccuDate XL terminals that closely align the terminal with needs specific to their operations. Our ability to provide these customized solutions is a key differentiator that we anticipate will help us to establish long-term relationships with our customers. Looking ahead, we remain positioned to benefit from increased food safety terminal opportunities as we further penetrate this growing market.
“Our POS automation business and opportunities for our print solutions continue to evolve. We are benefiting from strong sales of our Ithaca 9000 grill and receipt printer to McDonald’s in support of their ongoing technology and menu initiatives worldwide. We are also executing on what we see as a relatively new growth opportunity to leverage our Ithaca-branded printers for customer-facing kiosks in restaurant operations. We believe the longer-term opportunity and trends for these markets remain strong and TransAct is favorably positioned with reliable, value-enhancing print solutions that directly address market needs.
“While the global casino and gaming equipment market remains challenged on a macro basis, TransAct is leveraging its leadership position to drive growth and expand market share. Our innovation and market leadership was reaffirmed late in the third quarter of 2016 with a strong showing at the Global Gaming Expo in Las Vegas. In particular, we introduced our new Epic Edge casino ticket printer which was met with an enthusiastic response from casino operators. We also demonstrated two new versions of our Epicentral promotion and bonusing print system, including a new version that will allow TransAct to align our promotional and bonusing system directly with existing and future casino slot systems.”
Mr. Shuldman concluded, “Our high-margin, high-growth food safety and POS automation businesses continue to gain traction as we further execute in these key markets. The cash flow generated by our market-leading casino, gaming and lottery businesses allows us to invest in new, high-margin, technology-driven food safety and restaurant operation opportunities, and we expect to leverage our industry-leading solutions to deliver value for our shareholders in the form of additional growth and capital returns.”
Review of Balance Sheet and Capital Return Initiatives
As of September 30, 2016, TransAct had approximately $2.2 million of cash and cash equivalents and no debt. During the 2016 third quarter, the Company paid a dividend to shareholders of $0.08 per share and repurchased approximately 125,000 shares of its common stock for total consideration of approximately $1.0 million, resulting in a total return of capital to shareholders in the 2016 third quarter of nearly $1.6 million. Reflecting the 2016 third quarter repurchases, the Company had approximately $1.7 million remaining under its $5.0 million share repurchase authorization as of September 30, 2016.
Steve DeMartino, President and Chief Financial Officer of TransAct, added, “We continue to operate the business with an eye towards growing sales of our software and food safety products. We are generating strong operating cash flow which is deployed in support of ongoing product innovation and to return capital to shareholders through our regular quarterly cash dividend and ongoing share repurchases. During the 2016 third quarter, we continued to invest in our AccuDate and Epicentral product lines to deliver further technology and software enhancements that we believe will improve the value our customers place on these market-leading offerings. As we near the close of 2016 and head into 2017, we believe our consistent strong cash generation as well as our opportunities to innovate and capture market share in the food safety market, positions TransAct to deliver long-term returns for our shareholders.”
Summary of 2016 Third Quarter Operating Results
TransAct generated 2016 third quarter net sales of $14.5 million compared with net sales of $14.2 million in the 2015 third quarter. Food safety net sales (now disclosed as a separate line item in the table below) decreased $0.1 million year over year to $1.0 million in the 2016 third quarter, reflecting a larger order of AccuDate PRO terminals in the prior-year period which did not repeat this quarter offset in part by higher AccuDate 9700 sales. POS automation and banking net sales increased $0.6 million to $2.9 million in the 2016 third quarter compared to the 2015 third quarter. This increase reflects continued strength in sales of our Ithaca 9000 printer to McDonald’s in support of their new menu and technology initiatives. Casino and gaming net sales in the 2016 third quarter were $5.6 million compared to $4.4 million in the prior-year period, reflecting strong international printer sales and a new international Epicentral installation, partially offset by lower sales to the domestic casino printer market. Lottery printer net sales in the 2016 third quarter were $2.2 million compared with $1.8 million in the 2015 third quarter on stronger sales to IGT. Printrex net sales were $67,000 in the 2016 third quarter compared to $225,000 in the prior year period on continued weakness in the oil and gas industry, while the Company’s TransAct Services Group generated net sales of $2.7 million in the 2016 third quarter compared to net sales of $4.4 million in the prior year period due to an unusually high level of spare parts sales in the prior year period.
Gross margin of 40.9% in the 2016 third quarter compared to gross margin of 44.4% in the prior year period, reflecting increased sales of lower-margin Ithaca 9000 printers to McDonald’s and a decrease in high-margin spare parts sales in the 2016 third quarter. Total operating expenses for the 2016 third quarter remained consistent with the 2015 third quarter at $4.7 million, as higher engineering expenses to support our ongoing software and food safety terminal initiatives were offset by lower sales and marketing and general and administrative expenses.
TransAct recorded operating income of $1.2 million, or 8.5% of net sales, for the 2016 third quarter compared to $1.6 million, or 11.0% of net sales, in the 2015 third quarter. Net income in the 2016 third quarter was $0.9 million, or $0.12 per diluted share, compared to net income of $1.0 million, or $0.13 per diluted share, in the prior-year period.
2016 Third Quarter Conference Call and Webcast
TransAct is hosting a conference call and webcast today, November 2, 2016, beginning at 4:30 p.m. ET. Both the call and the webcast are open to the general public. The conference call number is 678-825-8259 and the conference ID number is 97852689 (domestic or international). Please call five minutes prior to the presentation to ensure that you are connected.
Interested parties may also access the conference call live on the Internet at www.transact-tech.com (select “Investor Relations” followed by “Events & Presentations”). Approximately two hours after the call has concluded, an archived version of the webcast will be available for replay at the same location.
Non-GAAP Financial Measures
TransAct is providing certain non-GAAP financial measures because the Company believes that these amounts are helpful to investors and others in assessing the ongoing nature of what the management views as TransAct's core operations. The Company believes that the non-GAAP financial measures of EBITDA, adjusted EBITDA, adjusted operating income, adjusted net income and adjusted net income per diluted share provide relevant and useful information, which is widely used by analysts, investors and competitors in the Company’s markets, as well as by the Company’s management in assessing the Company’s performance. These non-GAAP measures exclude the effect in the applicable periods presented of certain items that are contained in the tables included with this release. These items, which include the impact of legal fees incurred in the first nine months of 2015 related to the now-settled lawsuit with Avery Dennison Corporation, have been excluded from non-GAAP financial measures because management does not believe that they are representative of underlying trends in the Company's performance. Their exclusion provides investors and others with additional information to more readily assess the Company's operating results. The Company uses the non-GAAP financial measures internally to focus management on the results of the Company's core business. The presentation of this additional non-GAAP information is not considered superior to or a substitute for, and should be read in conjunction with, the financial information prepared in accordance with GAAP.
EBITDA is defined as net income before net interest expense, income taxes, depreciation and amortization. A reconciliation of EBITDA to net income, the most comparable GAAP financial measure, can be found attached to this release.
Adjusted EBITDA is defined as net income before net interest expense, income taxes, depreciation, and amortization and is adjusted for share-based compensation and the impact of legal fees related to the lawsuit with Avery Dennison Corporation in the first nine months of 2015. The Company adjusts EBITDA for share-based compensation as the Company considers share-based compensation to be a non-cash expense similar to depreciation and amortization, and believes that it provides investors with an additional measure of the Company’s liquidity. A reconciliation of adjusted EBITDA to net income, the most comparable GAAP financial measure, can be found attached to this release.
EBITDA and adjusted EBITDA provide the Company with an understanding of one aspect of earnings before the impact of investing and financing charges and income taxes. EBITDA and adjusted EBITDA may be useful to an investor in evaluating the Company’s operating performance and liquidity because this measure is: (i) widely used by investors to measure a company’s operating performance without regard to items excluded from the calculation of such measure; (ii) a financial measurement that is used by lenders and other parties to evaluate creditworthiness and liquidity; and (iii) used by the Company’s management for various purposes including strategic planning and forecasting, assessing financial performance and liquidity, and paying incentive compensation.
Adjusted operating income is defined as operating income adjusted for special items (the impact of legal fees related to the lawsuit with Avery Dennison Corporation incurred in the first nine months of 2015). The Company adjusts for these legal fees because the Avery Dennison lawsuit does not relate to the Company’s core business and because it believes that eliminating the legal fees helps investors understand, assess and develop expectations for the Company’s core business. A reconciliation of adjusted operating income to operating income, the most comparable GAAP financial measure, can be found attached to this release.
Adjusted net income is defined as net income adjusted for the tax-effected impact of special (legal fees related to the lawsuit with Avery Dennison Corporation incurred in first nine months of 2015). A reconciliation of adjusted net income to net income, the most comparable GAAP financial measure, can be found attached to this release.
Adjusted net income per diluted share is defined as adjusted net income divided by diluted shares outstanding. A reconciliation of adjusted net income per diluted share to net income per diluted share, the most comparable GAAP financial measure, can be found attached to this release.
Adjusted operating income, adjusted net income and adjusted net income per diluted share provide the Company with an understanding of the results of the primary operations of the business by excluding the effects of special items (legal fees related to the lawsuit with Avery Dennison Corporation) that do not reflect the ordinary earnings of the Company’s operations. The Company uses these measures to evaluate period-over-period operating performance because the Company believes this provides a more comparable measure of its continuing business as it adjusts for special items that are not reflective of the normal results of the business. These measures may be useful to an investor in evaluating the underlying operating performance of the Company’s business.
About TransAct Technologies Incorporated
TransAct Technologies Incorporated is a global leader in developing software-driven technology and printing solutions for high-growth markets including food safety, POS automation, casino and gaming, lottery, mobile and oil and gas. The Company’s solutions are designed from the ground up based on customer requirements and are sold under the AccuDate™, EPICENTRAL®, Epic®, Ithaca®, RESPONDER and Printrex® brands. TransAct has over 3.0 million printers and terminals installed around the world and is committed to providing world-class service, spare parts and accessories to support its installed product base. Through the TransAct Services Group, the Company also provides customers with a complete range of supplies and consumable items both online at http://www.transactsupplies.com and through its direct sales team. TransAct is headquartered in Hamden, CT. For more information, please visit http://www.transact-tech.com or call (203) 859-6800.
Forward-Looking Statements
Certain statements in this press release include forward-looking statements. Forward-looking statements generally can be identified by the use of forward-looking terminology, such as "may", "will", "expect", "intend", "estimate", "anticipate", "believe" or "continue" or the negative thereof or other similar words. All forward-looking statements involve risks and uncertainties, including, but not limited to, customer acceptance and market share gains, both domestically and internationally, in the face of substantial competition from competitors that have broader lines of products and greater financial resources; our competitors introducing new products into the marketplace; our ability to successfully develop new products; our dependence on significant customers; our dependence on significant vendors; dependence on contract manufacturers for the assembly of a large portion of our products in Asia; our ability to protect intellectual property; our ability to recruit and retain quality employees as the Company grows; our dependence on third parties for sales outside the United States, including Australia, New Zealand, Europe, Latin America and Asia; the economic and political conditions in the United States, Australia, New Zealand, Europe, Latin America and Asia; marketplace acceptance of new products; risks associated with foreign operations; the availability of third-party components at reasonable prices; price wars or other significant pricing pressures affecting the Company's products in the United States or abroad; risks associated with potential future acquisitions; the risk that our new line of food safety and oil and gas products will not drive increased adoption by customers; and other risk factors detailed in TransAct's Annual Report on Form 10-K and other reports filed with the Securities and Exchange Commission. Actual results may differ materially from those discussed in, or implied by, the forward-looking statements. The forward-looking statements speak only as of the date of this release and the Company assumes no duty to update them to reflect new, changing or unanticipated events or circumstances.
# # #
Investor Contact:
|
Steve DeMartino
President and Chief Financial Officer
TransAct Technologies Incorporated
203-859-6810
|
Richard Land, Joseph Jaffoni, Jim Leahy
JCIR
212-835-8500 or tact@jcir.com
|
- Financial tables follow -
|
TRANSACT TECHNOLOGIES INCORPORATED
|
|||||||||||||||
|
CONSOLIDATED STATEMENTS OF INCOME
|
|||||||||||||||
|
(Unaudited)
|
|||||||||||||||
|
Three Months Ended
|
Nine Months Ended
|
||||||||||||||
|
(In thousands, except per share amounts)
|
September 30,
|
September 30,
|
|||||||||||||
|
2016
|
2015
|
2016
|
2015
|
||||||||||||
|
Net sales
|
$ | 14,474 | $ | 14,172 | $ | 43,632 | $ | 47,560 | |||||||
|
Cost of sales
|
8,559 | 7,881 | 25,849 | 27,616 | |||||||||||
|
Gross profit
|
5,915 | 6,291 | 17,783 | 19,944 | |||||||||||
|
Operating expenses:
|
|||||||||||||||
|
Engineering, design and product development
|
1,133 | 766 | 3,458 | 2,494 | |||||||||||
|
Selling and marketing
|
1,808 | 2,137 | 5,460 | 6,060 | |||||||||||
|
General and administrative
|
1,737 | 1,823 | 5,589 | 5,665 | |||||||||||
|
Legal fees and settlement expenses associated with lawsuit
|
- | - | - | 1,738 | |||||||||||
| 4,678 | 4,726 | 14,507 | 15,957 | ||||||||||||
|
Operating income
|
1,237 | 1,565 | 3,276 | 3,987 | |||||||||||
|
Interest and other income (expense):
|
|||||||||||||||
|
Interest, net
|
(7) | (7) | (18) | (23) | |||||||||||
|
Other, net
|
(3) | 11 | 13 | (1) | |||||||||||
| (10) | 4 | (5) | (24) | ||||||||||||
|
Income before income taxes
|
1,227 | 1,569 | 3,271 | 3,963 | |||||||||||
|
Income tax provision
|
344 | 541 | 1,010 | 1,403 | |||||||||||
|
Net income
|
$ | 883 | $ | 1,028 | $ | 2,261 | $ | 2,560 | |||||||
|
Net income per common share:
|
|||||||||||||||
|
Basic
|
$ | 0.12 | $ | 0.13 | $ | 0.29 | $ | 0.33 | |||||||
|
Diluted
|
$ | 0.12 | $ | 0.13 | $ | 0.29 | $ | 0.33 | |||||||
|
Shares used in per share calculation:
|
|||||||||||||||
|
Basic
|
7,498 | 7,800 | 7,673 | 7,818 | |||||||||||
|
Diluted
|
7,549 | 7,848 | 7,724 | 7,844 | |||||||||||
|
SUPPLEMENTAL INFORMATION – SALES BY SALES UNIT:
|
|||||||||||||||
|
(In thousands)
|
Three months ended
|
Nine months ended
|
|||||||||||||
|
September 30,
|
September 30,
|
||||||||||||||
|
2016
|
2015
|
2016
|
2015
|
||||||||||||
|
Food safety
|
$ | 969 | $ | 1,107 | $ | 3,506 | $ | 2,961 | |||||||
|
POS automation and banking
|
2,889 | 2,274 | 8,407 | 6,069 | |||||||||||
|
Casino and gaming
|
5,612 | 4,399 | 16,204 | 17,237 | |||||||||||
|
Lottery
|
2,226 | 1,797 | 7,311 | 8,767 | |||||||||||
|
Printrex
|
67 | 225 | 398 | 1,152 | |||||||||||
|
TransAct Services Group
|
2,711 | 4,370 | 7,806 | 11,374 | |||||||||||
|
Total net sales
|
$ | 14,474 | $ | 14,172 | $ | 43,632 | $ | 47,560 | |||||||
|
TRANSACT TECHNOLOGIES INCORPORATED
|
|||||||
|
CONSOLIDATED BALANCE SHEETS
|
|||||||
|
(Unaudited)
|
|||||||
|
September 30,
|
December 31,
|
||||||
|
(In thousands)
|
2016
|
2015
|
|||||
|
Assets:
|
|||||||
|
Current assets:
|
|||||||
|
Cash and cash equivalents
|
$ | 2,199 | $ | 4,473 | |||
|
Accounts receivable, net
|
10,478 | 7,174 | |||||
|
Inventories
|
9,439 | 11,296 | |||||
|
Deferred tax assets
|
1,672 | 1,932 | |||||
|
Other current assets
|
1,121 | 437 | |||||
|
Total current assets
|
24,909 | 25,312 | |||||
|
Fixed assets, net
|
2,420 | 2,507 | |||||
|
Goodwill
|
2,621 | 2,621 | |||||
|
Deferred tax assets
|
1,311 | 1,213 | |||||
|
Intangible assets, net
|
643 | 888 | |||||
|
Other assets
|
38 | 28 | |||||
| 7,033 | 7,257 | ||||||
|
Total assets
|
$ | 31,942 | $ | 32,569 | |||
|
Liabilities and Shareholders’ Equity:
|
|||||||
|
Current liabilities:
|
|||||||
|
Accounts payable
|
$ | 5,614 | $ | 2,642 | |||
|
Accrued liabilities
|
2,129 | 2,838 | |||||
|
Income taxes payable
|
5 | 245 | |||||
|
Deferred revenue
|
132 | 604 | |||||
|
Total current liabilities
|
7,880 | 6,329 | |||||
|
Deferred revenue, net of current portion
|
76 | 77 | |||||
|
Deferred rent, net of current portion
|
188 | 189 | |||||
|
Other liabilities
|
240 | 246 | |||||
| 504 | 512 | ||||||
|
Total liabilities
|
8,384 | 6,841 | |||||
|
Shareholders’ equity:
|
|||||||
|
Common stock
|
112 | 112 | |||||
|
Additional paid-in capital
|
29,580 | 28,921 | |||||
|
Retained earnings
|
23,390 | 22,956 | |||||
|
Accumulated other comprehensive loss, net of tax
|
(101) | (80) | |||||
|
Treasury stock, at cost
|
(29,423) | (26,181) | |||||
|
Total shareholders’ equity
|
23,558 | 25,728 | |||||
|
Total liabilities and shareholders’ equity
|
$ | 31,942 | $ | 32,569 | |||
|
TRANSACT TECHNOLOGIES INCORPORATED
|
|
RECONCILIATION OF NON-GAAP EARNINGS FINANCIAL MEASURES TO CORRESPONDING
GAAP FINANCIAL MEASURES
|
|
(Unaudited, thousands of dollars, except percentages and per share amounts)
|
|
Three months ended
September 30, 2016
|
|||||||||||
|
Reported
|
Adjustments(1)
|
Adjusted
Non-GAAP
|
|||||||||
|
Operating expenses
|
$ | 4,678 | $ | - | $ | 4,678 | |||||
|
% of net sales
|
32.3% | 32.3% | |||||||||
|
Operating income
|
1,237 | - | 1,237 | ||||||||
|
% of net sales
|
8.5% | 8.5% | |||||||||
|
Income before income taxes
|
1,227 | - | 1,227 | ||||||||
|
Income tax provision
|
344 | - | 344 | ||||||||
|
Net income
|
883 | - | 883 | ||||||||
|
Net income per diluted share
|
$ | 0.12 | $ | - | $ | 0.12 | |||||
|
(1)
|
No adjustments.
|
|
|
|
Three months ended
September 30, 2015
|
|||||||||||
|
Reported
|
Adjustments (2)
|
Adjusted
Non-GAAP
|
|||||||||
|
Operating expenses
|
$ | 4,726 | $ | - | $ | 4,726 | |||||
|
% of net sales
|
33.3% | 33.3% | |||||||||
|
Operating income
|
1,565 | - | 1,565 | ||||||||
|
% of net sales
|
11.0% | 11.0% | |||||||||
|
Income before income taxes
|
1,569 | - | 1,569 | ||||||||
|
Income tax provision
|
541 | - | 541 | ||||||||
|
Net income
|
1,028 | - | 1,028 | ||||||||
|
Net income per diluted share
|
$ | 0.13 | $ | - | $ | 0.13 | |||||
|
(2)
|
No adjustments.
|
|
TRANSACT TECHNOLOGIES INCORPORATED
|
|
RECONCILIATION OF NON-GAAP EARNINGS FINANCIAL MEASURES TO CORRESPONDING
GAAP FINANCIAL MEASURES
|
|
(Unaudited, thousands of dollars, except percentages and per share amounts)
|
|
Nine months ended
September 30, 2016
|
|||||||||||
|
Reported
|
Adjustments(3)
|
Adjusted
Non-GAAP
|
|||||||||
|
Operating expenses
|
$ | 14,507 | $ | - | $ | 14,507 | |||||
|
% of net sales
|
33.2% | 33.2% | |||||||||
|
Operating income
|
3,276 | - | 3,276 | ||||||||
|
% of net sales
|
7.5% | 7.5% | |||||||||
|
Income before income taxes
|
3,271 | - | 3,271 | ||||||||
|
Income tax provision
|
1,010 | - | 1,010 | ||||||||
|
Net income
|
2,261 | - | 2,261 | ||||||||
|
Net income per diluted share
|
$ | 0.29 | $ | - | $ | 0.29 | |||||
|
(3)
|
No adjustments.
|
|
|
|
Nine months ended
September 30, 2015
|
|||||||||||
|
Reported
|
Adjustments (4)
|
Adjusted
Non-GAAP
|
|||||||||
|
Operating expenses
|
$ | 15,957 | $ | (1,738 | ) | $ | 14,219 | ||||
|
% of net sales
|
33.6% | 29.9% | |||||||||
|
Operating income
|
3,987 | 1,738 | 5,725 | ||||||||
|
% of net sales
|
8.4% | 12.0% | |||||||||
|
Income before income taxes
|
3,963 | 1,738 | 5,701 | ||||||||
|
Income tax provision
|
1,403 | 626 | 2,029 | ||||||||
|
Net income
|
2,560 | 1,112 | 3,672 | ||||||||
|
Net income per diluted share
|
$ | 0.33 | $ | 0.14 | $ | 0.47 | |||||
|
(4)
|
Adjustments include $1,763 of legal and other expenses partially offset by a $25 reversal of accrued settlement expenses related to the lawsuit with Avery Dennison Corporation. Such adjustments were tax effected using an effective tax rate of 36%.
|
|
TRANSACT TECHNOLOGIES INCORPORATED
|
|
RECONCILIATION OF EBITDA AND ADJUSTED EBITDA
TO CORRESPONDING GAAP FINANCIAL MEASURES
|
|
(Unaudited)
|
|
Three Months Ended
|
Nine Months Ended
|
||||||||||||||
|
(In thousands)
|
September 30,
|
September 30,
|
|||||||||||||
|
2016
|
2015
|
2016
|
2015
|
||||||||||||
|
Net income
|
$ | 883 | $ | 1,028 | $ | 2,261 | $ | 2,560 | |||||||
|
Interest expense, net
|
7 | 7 | 18 | 23 | |||||||||||
|
Income tax provision
|
344 | 541 | 1,010 | 1,403 | |||||||||||
|
Depreciation and amortization
|
319 | 343 | 962 | 1,077 | |||||||||||
|
EBITDA
|
1,553 | 1,919 | 4,251 | 5,063 | |||||||||||
|
Share-based compensation expense
|
168 | 108 | 473 | 377 | |||||||||||
|
Legal fees and settlement expenses associated with lawsuit
|
- | - | - | 1,738 | |||||||||||
|
Adjusted EBITDA
|
$ | 1,721 | $ | 2,027 | 4,724 | $ | 7,178 | ||||||||